2019.03.15

Renovation work – completed

We have completed renovation work at our R&D centre. We launched new laboratories and we are back to business as usual. A dedicated modular ... More
2019.02.27

Five life science start-ups that can change the world

We have found ourselves in the ranking of the 5 most promising Polish start-ups prepared by Money.pl! “From those looking for a drug to cure ... More
2019.02.01

Łukasz Bzdzion on Radio Wrocław

Łukasz Bzdzion visited Filip Marczyński on Radio Wrocław. The CEO of Bioceltix talked about biological drugs for animals that are currently ... More
2019.01.28

Veterinary biological drugs – Bioceltix summarizes the year 2018

For Bioceltix, last year was filled with new, exciting challenges. From rankings and accelerator programs to contests and even a newly-opened ... More
2019.01.24

The Chivas Venture finale

The final of the Chivas Ventures contest took place last week. We are extremely happy to have had the opportunity to meet some many creative ... More
2019.01.09

MIT Enterprise Forum Poland: DemoDay

On Tuesday (8th January) startups participating in the MIT Enterprise Forum Poland competition had a chance to present their innovative ... More
2018.12.24

Merry Christmas and happy New Year!

On behalf of the entire Bioceltix team, we would like to wish you a very successful, healthy and joyful New Year. We look forward to our work ... More
2018.12.19

Bioceltix is ​​working on drugs based on stem cells for animals [interview]

MamStartup: Bioceltix is a biotech startup that does business in the veterinary industry – the company focuses on developing ... More
2018.12.04

Innowacje na start: Chivas Venture and Bioceltix

We hope you had a chance to tune in to „Radio dla Ciebie” during the „Let’s start with Innovation” („Innowacje na start”) show – that’s for ... More
2018.12.03

Bioceltix has made it to the final round of Chivas Ventures

Another round of the prestigious contest designed for social-involved startups – Chivas Venture–  is behind us. We are among the five ... More